Patent details
EP2303313 Title: EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES
Basic Information
- Publication number:
- EP2303313
- PCT Application Number:
- PCT/US/2009/044727
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097515134
- PCT Publication Number:
- WO/2009/143285
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES
- French Title of Invention:
- EXENDINES POUR DIMINUER LE CHOLESTÉROL ET LES TRIGLYCÉRIDES
- German Title of Invention:
- EXENDINE ZUR SENKUNG DER CHOLESTERIN- UND TRIGLYCERIDWERTE
- SPC Number:
Dates
- Filing date:
- 20/05/2009
- Grant date:
- 28/10/2015
- EP Publication Date:
- 28/10/2015
- PCT Publication Date:
- 26/11/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/04/2011
- EP B1 Publication Date:
- 28/10/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/05/2016
- Expiration date:
- 20/05/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/12/2015
- Name:
- Amylin Pharmaceuticals LLC
- Address:
- 1800 Concord Pike, Wilmington, DE 19850, United States (US)
- Name:
- AstraZeneca Pharmaceuticals LP
- Address:
- 1800 Concord Pike, Wilmington, DE, United States (US)
Inventor
1
- Name:
- MACCONELL Leigh
- Address:
- United States (US)
2
- Name:
- TAYLOR Kristin
- Address:
- United States (US)
3
- Name:
- FINEMAN Mark
- Address:
- United States (US)
Priority
- Priority Number:
- 54883 P
- Priority Date:
- 21/05/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/22;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|